The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID : VEN/AZA effectively targets AML clones. (2022). Mediterranean Journal of Hematology and Infectious Diseases, 14(1), e2022041. https://doi.org/10.4084/MJHID.2022.041